Antibody responses against NY-ESO-1 and HER2 antigens in patients vaccinated with combinations of cholesteryl pullulan (CHP)-NY-ESO-1 and CHP-HER2 with OK-432-Reference-Cited by-同舟云学术

Antibody responses against NY-ESO-1 and HER2 antigens in patients vaccinated with combinations of cholesteryl pullulan (CHP)-NY-ESO-1 and CHP-HER2 with OK-432

Published:2009-11 Issue:49 Volume:27 Page:6854-6861
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Aoki Masatoshi,Ueda Shugo,Nishikawa Hiroyoshi,Kitano Shigehisa,Hirayama Michiko,Ikeda Hiroaki,Toyoda Hideki,Tanaka Kyosuke,Kanai Michiyuki,Takabayashi Arimichi,Imai Hiroshi,Shiraishi Taizo,Sato Eiichi,Wada Hisashi,Nakayama Eiichi,Takei Yoshiyuki,Katayama Naoyuki,Shiku Hiroshi,Kageyama Shinichi

Funder

Ministry of Education, Culture, Sports, Science and Technology of Japan for Scientific Research on Priority Areas, Cancer Translational Research Project, Japan

Cancer Research Institute, New York, USA

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference31 articles.

1. Macromolecular complexation between bovine serum albumin and the self-assembled hydrogel nanoparticle of hydrophobized polysaccharides;Nishikawa;J Am Chem Soc,1996

2. Presentation of a major histocompatibility complex class 1-binding peptide by monocyte-derived dendritic cells incorporating hydrophobized polysaccharide-truncated HER2 protein complex: implications for a polyvalent immuno-cell therapy;Ikuta;Blood,2002

3. A novel hydrophobized polysaccharide/oncoprotein complex vaccine induces in vitro and in vivo cellular and humoral immune responses against HER2-expressing murine sarcomas;Gu;Cancer Res,1998

4. HER2-specific T-cell immune responses in patients vaccinated with truncated HER2 protein complexed with nanogels of cholesteryl pullulan;Kitano;Clin Cancer Res,2006

5. Humoral immune responses in patients vaccinated with 1-146 HER2 protein complexed with cholesteryl pullulan nanogel;Kageyama;Cancer Sci,2008

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A phase 1 trial of NY‐ESO‐1‐specific TCR‐engineered T‐cell therapy combined with a lymph node‐targeting nanoparticulate peptide vaccine for the treatment of advanced soft tissue sarcoma;International Journal of Cancer;2023-02-17

2. Nanogels as target drug delivery systems in cancer therapy: A review of the last decade;Frontiers in Pharmacology;2022-09-08

3. Advanced Hydrogels for the Controlled Delivery of Insulin;Pharmaceutics;2021-12-08

4. Safety and antibody immune response of CHP-NY-ESO-1 vaccine combined with poly-ICLC in advanced or recurrent esophageal cancer patients;Cancer Immunology, Immunotherapy;2021-03-22

5. First-in-human phase I clinical trial of the NY-ESO-1 protein cancer vaccine with NOD2 and TLR9 stimulants in patients with NY-ESO-1-expressing refractory solid tumors;Cancer Immunology, Immunotherapy;2020-01-24